Avid Bioservices Inc (NASDAQ:CDMO)
| 15.28 Delayed Data As of 4:01pm ET |  +0.07 / +0.46%Today’s Change | 11.30 Today|||52-Week Range 34.51 | -47.64% Year-to-Date |
Latest CDMO News | Press Releases
| Avid Bioservices, Inc. (CDMO) Q4 2022 Earnings Call Transcript 3:00am / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 15.21 |
| Today’s open | 14.89 |
| Day’s range | 13.96 - 15.37 |
| Volume | 14,430 |
| Average volume (3 months) | 626,191 |
| Market cap | $963.2M |
Data as of 4:01pm ET, 06/30/2022
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +295.83% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +60.58% |
| P/E ratio | 101.9 |
| Price/Sales | 13.27 |
| Price/Book | 12.26 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| IMGNImmunoGen Inc | +0.14 | +3.21% |
| MRUSMerus NV | +0.63 | +2.85% |
| DCPHDeciphera Pharmaceut... | -0.31 | -2.26% |
| QUREUniqure NV | +0.13 | +0.70% |
Data as of 4:01pm ET, 06/30/2022
Financials
| Next reporting date | September 8, 2022 |
| EPS forecast (this quarter) | $0.05 |
| Annual revenue (last year) | $95.9M |
| Annual profit (last year) | $11.2M |
| Net profit margin | 11.70% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Tustin, California |
Forecasts
